APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

GABA Receptor Agonist Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global GABA Receptor Agonist Drug Market Analysis and Forecast 2026-2032

22 December 2025208 pages

Choose your research edition.

Industry ResearchGABA Receptor Agonist Drug Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal GABA Receptor Agonist Drug Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal GABA Receptor Agonist Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal GABA Receptor Agonist Drug Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal GABA Receptor Agonist Drug Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global GABA Receptor Agonist Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for GABA Receptor Agonist Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for GABA Receptor Agonist Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for GABA Receptor Agonist Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for GABA Receptor Agonist Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of GABA Receptor Agonist Drug include Novartis, Eli Lilly and Company, Pfizer, GlaxoSmithKline, AstraZeneca, XenoPort, VIVUS, sanofi-aventis and OVATION Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for GABA Receptor Agonist Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of GABA Receptor Agonist Drug, also provides the sales of main regions and countries. Of the upcoming market potential for GABA Receptor Agonist Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the GABA Receptor Agonist Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global GABA Receptor Agonist Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for GABA Receptor Agonist Drug sales, projected growth trends, production technology, application and end-user industry.

GABA Receptor Agonist Drug Segment by Company

Novartis

Eli Lilly and Company

Pfizer

GlaxoSmithKline

AstraZeneca

XenoPort

VIVUS

sanofi-aventis

OVATION Pharmaceuticals

Osmotica Pharmaceutical

NovaDel Pharma

H.LundBeck, Merck and Co

Elan Corporation

Biocodex

Athena Drug Delivery Solutions

Advicenne

GABA Receptor Agonist Drug Segment by Type

Baclofen

Bamaluzole

Phenibut

Gaboxadol

Klonopin (clonazepam)

Tiagbine

GABA Receptor Agonist Drug Segment by Application

Alzheimer

Epilepsy and Seizure

Obesity and Alcoholism

Anxiety and Sleep Disorders

Psychiatric Disorders and Depression

Attention Deficit Hyperactivity Disorder (ADHD)

GABA Receptor Agonist Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GABA Receptor Agonist Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of GABA Receptor Agonist Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GABA Receptor Agonist Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of GABA Receptor Agonist Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of GABA Receptor Agonist Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, GABA Receptor Agonist Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global GABA Receptor Agonist Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Baclofen Major Manufacturers Table 3. Bamaluzole Major Manufacturers Table 4. Phenibut Major Manufacturers Table 5. Gaboxadol Major Manufacturers Table 6. Klonopin (clonazepam) Major Manufacturers Table 7. Tiagbine Major Manufacturers Table 8. Global GABA Receptor Agonist Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Alzheimer Major Manufacturers Table 10. Epilepsy and Seizure Major Manufacturers Table 11. Obesity and Alcoholism Major Manufacturers Table 12. Anxiety and Sleep Disorders Major Manufacturers Table 13. Psychiatric Disorders and Depression Major Manufacturers Table 14. Attention Deficit Hyperactivity Disorder (ADHD) Major Manufacturers Table 15. GABA Receptor Agonist Drug Industry Trends Table 16. GABA Receptor Agonist Drug Industry Drivers Table 17. GABA Receptor Agonist Drug Industry Opportunities and Challenges Table 18. GABA Receptor Agonist Drug Industry Restraints Table 19. Global GABA Receptor Agonist Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global GABA Receptor Agonist Drug Revenue by Region (2021-2026) & (US$ Million) Table 21. Global GABA Receptor Agonist Drug Revenue by Region (2027-2032) & (US$ Million) Table 22. Global GABA Receptor Agonist Drug Revenue Market Share by Region (2021-2026) Table 23. Global GABA Receptor Agonist Drug Revenue Market Share by Region (2027-2032) Table 24. Global GABA Receptor Agonist Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 25. Global GABA Receptor Agonist Drug Sales by Region (2021-2026) & (k units) Table 26. Global GABA Receptor Agonist Drug Sales by Region (2027-2032) & (k units) Table 27. Global GABA Receptor Agonist Drug Sales Market Share by Region (2021-2026) Table 28. Global GABA Receptor Agonist Drug Sales Market Share by Region (2027-2032) Table 29. Global GABA Receptor Agonist Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 30. Global GABA Receptor Agonist Drug Revenue Market Share by Manufacturers (2021-2026) Table 31. Global GABA Receptor Agonist Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 32. Global GABA Receptor Agonist Drug Sales Market Share by Manufacturers (2021-2026) Table 33. Global GABA Receptor Agonist Drug Sales Price (US$/unit) of Manufacturers (2021-2026) Table 34. Global GABA Receptor Agonist Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 35. Global GABA Receptor Agonist Drug Key Manufacturers Manufacturing Sites & Headquarters Table 36. Global GABA Receptor Agonist Drug Manufacturers, Product Type & Application Table 37. Global GABA Receptor Agonist Drug Manufacturers' Establishment Date Table 38. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 39. Global GABA Receptor Agonist Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global GABA Receptor Agonist Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global GABA Receptor Agonist Drug Revenue by Type (2021-2026) & (US$ Million) Table 42. Global GABA Receptor Agonist Drug Revenue by Type (2027-2032) & (US$ Million) Table 43. Global GABA Receptor Agonist Drug Revenue Market Share by Type (2021-2026) Table 44. Global GABA Receptor Agonist Drug Revenue Market Share by Type (2027-2032) Table 45. Global GABA Receptor Agonist Drug Sales by Type 2021 VS 2025 VS 2032 (k units) Table 46. Global GABA Receptor Agonist Drug Sales by Type (2021-2026) & (k units) Table 47. Global GABA Receptor Agonist Drug Sales by Type (2027-2032) & (k units) Table 48. Global GABA Receptor Agonist Drug Sales Market Share by Type (2021-2026) Table 49. Global GABA Receptor Agonist Drug Sales Market Share by Type (2027-2032) Table 50. Global GABA Receptor Agonist Drug Price by Type (2021-2026) & (US$/unit) Table 51. Global GABA Receptor Agonist Drug Price by Type (2027-2032) & (US$/unit) Table 52. Global GABA Receptor Agonist Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global GABA Receptor Agonist Drug Revenue by Application (2021-2026) & (US$ Million) Table 54. Global GABA Receptor Agonist Drug Revenue by Application (2027-2032) & (US$ Million) Table 55. Global GABA Receptor Agonist Drug Revenue Market Share by Application (2021-2026) Table 56. Global GABA Receptor Agonist Drug Revenue Market Share by Application (2027-2032) Table 57. Global GABA Receptor Agonist Drug Sales by Application 2021 VS 2025 VS 2032 (k units) Table 58. Global GABA Receptor Agonist Drug Sales by Application (2021-2026) & (k units) Table 59. Global GABA Receptor Agonist Drug Sales by Application (2027-2032) & (k units) Table 60. Global GABA Receptor Agonist Drug Sales Market Share by Application (2021-2026) Table 61. Global GABA Receptor Agonist Drug Sales Market Share by Application (2027-2032) Table 62. Global GABA Receptor Agonist Drug Price by Application (2021-2026) & (US$/unit) Table 63. Global GABA Receptor Agonist Drug Price by Application (2027-2032) & (US$/unit) Table 64. Novartis Company Information Table 65. Novartis Business Overview Table 66. Novartis GABA Receptor Agonist Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Novartis GABA Receptor Agonist Drug Product Portfolio Table 68. Novartis Recent Development Table 69. Eli Lilly and Company Company Information Table 70. Eli Lilly and Company Business Overview Table 71. Eli Lilly and Company GABA Receptor Agonist Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Eli Lilly and Company GABA Receptor Agonist Drug Product Portfolio Table 73. Eli Lilly and Company Recent Development Table 74. Pfizer Company Information Table 75. Pfizer Business Overview Table 76. Pfizer GABA Receptor Agonist Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Pfizer GABA Receptor Agonist Drug Product Portfolio Table 78. Pfizer Recent Development Table 79. GlaxoSmithKline Company Information Table 80. GlaxoSmithKline Business Overview Table 81. GlaxoSmithKline GABA Receptor Agonist Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. GlaxoSmithKline GABA Receptor Agonist Drug Product Portfolio Table 83. GlaxoSmithKline Recent Development Table 84. AstraZeneca Company Information Table 85. AstraZeneca Business Overview Table 86. AstraZeneca GABA Receptor Agonist Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. AstraZeneca GABA Receptor Agonist Drug Product Portfolio Table 88. AstraZeneca Recent Development Table 89. XenoPort Company Information Table 90. XenoPort Business Overview Table 91. XenoPort GABA Receptor Agonist Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. XenoPort GABA Receptor Agonist Drug Product Portfolio Table 93. XenoPort Recent Development Table 94. VIVUS Company Information Table 95. VIVUS Business Overview Table 96. VIVUS GABA Receptor Agonist Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. VIVUS GABA Receptor Agonist Drug Product Portfolio Table 98. VIVUS Recent Development Table 99. sanofi-aventis Company Information Table 100. sanofi-aventis Business Overview Table 101. sanofi-aventis GABA Receptor Agonist Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. sanofi-aventis GABA Receptor Agonist Drug Product Portfolio Table 103. sanofi-aventis Recent Development Table 104. OVATION Pharmaceuticals Company Information Table 105. OVATION Pharmaceuticals Business Overview Table 106. OVATION Pharmaceuticals GABA Receptor Agonist Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. OVATION Pharmaceuticals GABA Receptor Agonist Drug Product Portfolio Table 108. OVATION Pharmaceuticals Recent Development Table 109. Osmotica Pharmaceutical Company Information Table 110. Osmotica Pharmaceutical Business Overview Table 111. Osmotica Pharmaceutical GABA Receptor Agonist Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Osmotica Pharmaceutical GABA Receptor Agonist Drug Product Portfolio Table 113. Osmotica Pharmaceutical Recent Development Table 114. NovaDel Pharma Company Information Table 115. NovaDel Pharma Business Overview Table 116. NovaDel Pharma GABA Receptor Agonist Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. NovaDel Pharma GABA Receptor Agonist Drug Product Portfolio Table 118. NovaDel Pharma Recent Development Table 119. H.LundBeck, Merck and Co Company Information Table 120. H.LundBeck, Merck and Co Business Overview Table 121. H.LundBeck, Merck and Co GABA Receptor Agonist Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 122. H.LundBeck, Merck and Co GABA Receptor Agonist Drug Product Portfolio Table 123. H.LundBeck, Merck and Co Recent Development Table 124. Elan Corporation Company Information Table 125. Elan Corporation Business Overview Table 126. Elan Corporation GABA Receptor Agonist Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 127. Elan Corporation GABA Receptor Agonist Drug Product Portfolio Table 128. Elan Corporation Recent Development Table 129. Biocodex Company Information Table 130. Biocodex Business Overview Table 131. Biocodex GABA Receptor Agonist Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 132. Biocodex GABA Receptor Agonist Drug Product Portfolio Table 133. Biocodex Recent Development Table 134. Athena Drug Delivery Solutions Company Information Table 135. Athena Drug Delivery Solutions Business Overview Table 136. Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 137. Athena Drug Delivery Solutions GABA Receptor Agonist Drug Product Portfolio Table 138. Athena Drug Delivery Solutions Recent Development Table 139. Advicenne Company Information Table 140. Advicenne Business Overview Table 141. Advicenne GABA Receptor Agonist Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 142. Advicenne GABA Receptor Agonist Drug Product Portfolio Table 143. Advicenne Recent Development Table 144. North America GABA Receptor Agonist Drug Revenue by Type (2021-2026) & (US$ Million) Table 145. North America GABA Receptor Agonist Drug Revenue by Type (2027-2032) & (US$ Million) Table 146. North America GABA Receptor Agonist Drug Sales by Type (2021-2026) & (k units) Table 147. North America GABA Receptor Agonist Drug Sales by Type (2027-2032) & (k units) Table 148. North America GABA Receptor Agonist Drug Sales Price by Type (2021-2026) & (US$/unit) Table 149. North America GABA Receptor Agonist Drug Sales Price by Type (2027-2032) & (US$/unit) Table 150. North America GABA Receptor Agonist Drug Revenue by Application (2021-2026) & (US$ Million) Table 151. North America GABA Receptor Agonist Drug Revenue by Application (2027-2032) & (US$ Million) Table 152. North America GABA Receptor Agonist Drug Sales by Application (2021-2026) & (k units) Table 153. North America GABA Receptor Agonist Drug Sales by Application (2027-2032) & (k units) Table 154. North America GABA Receptor Agonist Drug Sales Price by Application (2021-2026) & (US$/unit) Table 155. North America GABA Receptor Agonist Drug Sales Price by Application (2027-2032) & (US$/unit) Table 156. North America GABA Receptor Agonist Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 157. North America GABA Receptor Agonist Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 158. North America GABA Receptor Agonist Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 159. North America GABA Receptor Agonist Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 160. North America GABA Receptor Agonist Drug Sales by Country (2021-2026) & (k units) Table 161. North America GABA Receptor Agonist Drug Sales by Country (2027-2032) & (k units) Table 162. North America GABA Receptor Agonist Drug Sales Price by Country (2021-2026) & (US$/unit) Table 163. North America GABA Receptor Agonist Drug Sales Price by Country (2027-2032) & (US$/unit) Table 164. United States GABA Receptor Agonist Drug Revenue (2021-2032) & (US$ Million) Table 165. Canada GABA Receptor Agonist Drug Revenue (2021-2032) & (US$ Million) Table 166. Mexico GABA Receptor Agonist Drug Revenue (2021-2032) & (US$ Million) Table 167. Europe GABA Receptor Agonist Drug Revenue by Type (2021-2026) & (US$ Million) Table 168. Europe GABA Receptor Agonist Drug Revenue by Type (2027-2032) & (US$ Million) Table 169. Europe GABA Receptor Agonist Drug Sales by Type (2021-2026) & (k units) Table 170. Europe GABA Receptor Agonist Drug Sales by Type (2027-2032) & (k units) Table 171. Europe GABA Receptor Agonist Drug Sales Price by Type (2021-2026) & (US$/unit) Table 172. Europe GABA Receptor Agonist Drug Sales Price by Type (2027-2032) & (US$/unit) Table 173. Europe GABA Receptor Agonist Drug Revenue by Application (2021-2026) & (US$ Million) Table 174. Europe GABA Receptor Agonist Drug Revenue by Application (2027-2032) & (US$ Million) Table 175. Europe GABA Receptor Agonist Drug Sales by Application (2021-2026) & (k units) Table 176. Europe GABA Receptor Agonist Drug Sales by Application (2027-2032) & (k units) Table 177. Europe GABA Receptor Agonist Drug Sales Price by Application (2021-2026) & (US$/unit) Table 178. Europe GABA Receptor Agonist Drug Sales Price by Application (2027-2032) & (US$/unit) Table 179. Europe GABA Receptor Agonist Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 180. Europe GABA Receptor Agonist Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 181. Europe GABA Receptor Agonist Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 182. Europe GABA Receptor Agonist Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 183. Europe GABA Receptor Agonist Drug Sales by Country (2021-2026) & (k units) Table 184. Europe GABA Receptor Agonist Drug Sales by Country (2027-2032) & (k units) Table 185. Europe GABA Receptor Agonist Drug Sales Price by Country (2021-2026) & (US$/unit) Table 186. Europe GABA Receptor Agonist Drug Sales Price by Country (2027-2032) & (US$/unit) Table 187. Germany GABA Receptor Agonist Drug Revenue (2021-2032) & (US$ Million) Table 188. France GABA Receptor Agonist Drug Revenue (2021-2032) & (US$ Million) Table 189. U.K. GABA Receptor Agonist Drug Revenue (2021-2032) & (US$ Million) Table 190. Italy GABA Receptor Agonist Drug Revenue (2021-2032) & (US$ Million) Table 191. Russia GABA Receptor Agonist Drug Revenue (2021-2032) & (US$ Million) Table 192. Spain GABA Receptor Agonist Drug Revenue (2021-2032) & (US$ Million) Table 193. Netherlands GABA Receptor Agonist Drug Revenue (2021-2032) & (US$ Million) Table 194. Switzerland GABA Receptor Agonist Drug Revenue (2021-2032) & (US$ Million) Table 195. Sweden GABA Receptor Agonist Drug Revenue (2021-2032) & (US$ Million) Table 196. Poland GABA Receptor Agonist Drug Revenue (2021-2032) & (US$ Million) Table 197. China GABA Receptor Agonist Drug Revenue by Type (2021-2026) & (US$ Million) Table 198. China GABA Receptor Agonist Drug Revenue by Type (2027-2032) & (US$ Million) Table 199. China GABA Receptor Agonist Drug Sales by Type (2021-2026) & (k units) Table 200. China GABA Receptor Agonist Drug Sales by Type (2027-2032) & (k units) Table 201. China GABA Receptor Agonist Drug Sales Price by Type (2021-2026) & (US$/unit) Table 202. China GABA Receptor Agonist Drug Sales Price by Type (2027-2032) & (US$/unit) Table 203. China GABA Receptor Agonist Drug Revenue by Application (2021-2026) & (US$ Million) Table 204. China GABA Receptor Agonist Drug Revenue by Application (2027-2032) & (US$ Million) Table 205. China GABA Receptor Agonist Drug Sales by Application (2021-2026) & (k units) Table 206. China GABA Receptor Agonist Drug Sales by Application (2027-2032) & (k units) Table 207. China GABA Receptor Agonist Drug Sales Price by Application (2021-2026) & (US$/unit) Table 208. China GABA Receptor Agonist Drug Sales Price by Application (2027-2032) & (US$/unit) Table 209. Asia GABA Receptor Agonist Drug Revenue by Type (2021-2026) & (US$ Million) Table 210. Asia GABA Receptor Agonist Drug Revenue by Type (2027-2032) & (US$ Million) Table 211. Asia GABA Receptor Agonist Drug Sales by Type (2021-2026) & (k units) Table 212. Asia GABA Receptor Agonist Drug Sales by Type (2027-2032) & (k units) Table 213. Asia GABA Receptor Agonist Drug Sales Price by Type (2021-2026) & (US$/unit) Table 214. Asia GABA Receptor Agonist Drug Sales Price by Type (2027-2032) & (US$/unit) Table 215. Asia GABA Receptor Agonist Drug Revenue by Application (2021-2026) & (US$ Million) Table 216. Asia GABA Receptor Agonist Drug Revenue by Application (2027-2032) & (US$ Million) Table 217. Asia GABA Receptor Agonist Drug Sales by Application (2021-2026) & (k units) Table 218. Asia GABA Receptor Agonist Drug Sales by Application (2027-2032) & (k units) Table 219. Asia GABA Receptor Agonist Drug Sales Price by Application (2021-2026) & (US$/unit) Table 220. Asia GABA Receptor Agonist Drug Sales Price by Application (2027-2032) & (US$/unit) Table 221. Asia GABA Receptor Agonist Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 222. Asia GABA Receptor Agonist Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 223. Asia GABA Receptor Agonist Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 224. Asia GABA Receptor Agonist Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 225. Asia GABA Receptor Agonist Drug Sales by Country (2021-2026) & (k units) Table 226. Asia GABA Receptor Agonist Drug Sales by Country (2027-2032) & (k units) Table 227. Asia GABA Receptor Agonist Drug Sales Price by Country (2021-2026) & (US$/unit) Table 228. Asia GABA Receptor Agonist Drug Sales Price by Country (2027-2032) & (US$/unit) Table 229. Japan GABA Receptor Agonist Drug Revenue (2021-2032) & (US$ Million) Table 230. South Korea GABA Receptor Agonist Drug Revenue (2021-2032) & (US$ Million) Table 231. India GABA Receptor Agonist Drug Revenue (2021-2032) & (US$ Million) Table 232. Australia GABA Receptor Agonist Drug Revenue (2021-2032) & (US$ Million) Table 233. Taiwan GABA Receptor Agonist Drug Revenue (2021-2032) & (US$ Million) Table 234. Southeast Asia GABA Receptor Agonist Drug Revenue (2021-2032) & (US$ Million) Table 235. SAMEA GABA Receptor Agonist Drug Revenue by Type (2021-2026) & (US$ Million) Table 236. SAMEA GABA Receptor Agonist Drug Revenue by Type (2027-2032) & (US$ Million) Table 237. SAMEA GABA Receptor Agonist Drug Sales by Type (2021-2026) & (k units) Table 238. SAMEA GABA Receptor Agonist Drug Sales by Type (2027-2032) & (k units) Table 239. SAMEA GABA Receptor Agonist Drug Sales Price by Type (2021-2026) & (US$/unit) Table 240. SAMEA GABA Receptor Agonist Drug Sales Price by Type (2027-2032) & (US$/unit) Table 241. SAMEA GABA Receptor Agonist Drug Revenue by Application (2021-2026) & (US$ Million) Table 242. SAMEA GABA Receptor Agonist Drug Revenue by Application (2027-2032) & (US$ Million) Table 243. SAMEA GABA Receptor Agonist Drug Sales by Application (2021-2026) & (k units) Table 244. SAMEA GABA Receptor Agonist Drug Sales by Application (2027-2032) & (k units) Table 245. SAMEA GABA Receptor Agonist Drug Sales Price by Application (2021-2026) & (US$/unit) Table 246. SAMEA GABA Receptor Agonist Drug Sales Price by Application (2027-2032) & (US$/unit) Table 247. SAMEA GABA Receptor Agonist Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 248. SAMEA GABA Receptor Agonist Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 249. SAMEA GABA Receptor Agonist Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 250. SAMEA GABA Receptor Agonist Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 251. SAMEA GABA Receptor Agonist Drug Sales by Country (2021-2026) & (k units) Table 252. SAMEA GABA Receptor Agonist Drug Sales by Country (2027-2032) & (k units) Table 253. SAMEA GABA Receptor Agonist Drug Sales Price by Country (2021-2026) & (US$/unit) Table 254. SAMEA GABA Receptor Agonist Drug Sales Price by Country (2027-2032) & (US$/unit) Table 255. Brazil GABA Receptor Agonist Drug Revenue (2021-2032) & (US$ Million) Table 256. Argentina GABA Receptor Agonist Drug Revenue (2021-2032) & (US$ Million) Table 257. Chile GABA Receptor Agonist Drug Revenue (2021-2032) & (US$ Million) Table 258. Colombia GABA Receptor Agonist Drug Revenue (2021-2032) & (US$ Million) Table 259. Peru GABA Receptor Agonist Drug Revenue (2021-2032) & (US$ Million) Table 260. Saudi Arabia GABA Receptor Agonist Drug Revenue (2021-2032) & (US$ Million) Table 261. Israel GABA Receptor Agonist Drug Revenue (2021-2032) & (US$ Million) Table 262. UAE GABA Receptor Agonist Drug Revenue (2021-2032) & (US$ Million) Table 263. Turkey GABA Receptor Agonist Drug Revenue (2021-2032) & (US$ Million) Table 264. Iran GABA Receptor Agonist Drug Revenue (2021-2032) & (US$ Million) Table 265. Egypt GABA Receptor Agonist Drug Revenue (2021-2032) & (US$ Million) Table 266. Key Raw Materials Table 267. Raw Materials Key Suppliers Table 268. GABA Receptor Agonist Drug Distributors List Table 269. GABA Receptor Agonist Drug Customers List Table 270. Research Programs/Design for This Report Table 271. Authors List of This Report Table 272. Secondary Sources Table 273. Primary Sources List of Figures Figure 1. GABA Receptor Agonist Drug Image Figure 2. Global GABA Receptor Agonist Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global GABA Receptor Agonist Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Baclofen Image Figure 5. Bamaluzole Image Figure 6. Phenibut Image Figure 7. Gaboxadol Image Figure 8. Klonopin (clonazepam) Image Figure 9. Tiagbine Image Figure 10. Global GABA Receptor Agonist Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global GABA Receptor Agonist Drug Market Size Share 2021 VS 2025 VS 2032 Figure 12. Alzheimer Image Figure 13. Epilepsy and Seizure Image Figure 14. Obesity and Alcoholism Image Figure 15. Anxiety and Sleep Disorders Image Figure 16. Psychiatric Disorders and Depression Image Figure 17. Attention Deficit Hyperactivity Disorder (ADHD) Image Figure 18. Global GABA Receptor Agonist Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 19. Global GABA Receptor Agonist Drug Revenue (2021-2032) & (US$ Million) Figure 20. Global GABA Receptor Agonist Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global GABA Receptor Agonist Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 22. Global GABA Receptor Agonist Drug Revenue Market Share by Region (2021-2032) Figure 23. Global GABA Receptor Agonist Drug Sales (2021-2032) & (k units) Figure 24. Global GABA Receptor Agonist Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 25. Global GABA Receptor Agonist Drug Sales Market Share by Region (2021-2032) Figure 26. US & Canada & Mexico GABA Receptor Agonist Drug Sales YoY (2021-2032) & (k units) Figure 27. Europe GABA Receptor Agonist Drug Sales YoY (2021-2032) & (k units) Figure 28. China GABA Receptor Agonist Drug Sales YoY (2021-2032) & (k units) Figure 29. Asia (Excluding China) GABA Receptor Agonist Drug Sales YoY (2021-2032) & (k units) Figure 30. South America, Middle East and Africa GABA Receptor Agonist Drug Sales YoY (2021-2032) & (k units) Figure 31. Global GABA Receptor Agonist Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 32. Global GABA Receptor Agonist Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 33. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 34. Global GABA Receptor Agonist Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global GABA Receptor Agonist Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global GABA Receptor Agonist Drug Revenue Market Share by Type (2021-2032) Figure 37. Global GABA Receptor Agonist Drug Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 38. Global GABA Receptor Agonist Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 39. Global GABA Receptor Agonist Drug Sales Market Share by Type (2021-2032) Figure 40. Global GABA Receptor Agonist Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 41. Global GABA Receptor Agonist Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global GABA Receptor Agonist Drug Revenue Market Share by Application (2021-2032) Figure 43. Global GABA Receptor Agonist Drug Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 44. Global GABA Receptor Agonist Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 45. Global GABA Receptor Agonist Drug Sales Market Share by Application (2021-2032) Figure 46. North America GABA Receptor Agonist Drug Revenue Share by Type (2021-2032) Figure 47. North America GABA Receptor Agonist Drug Sales Share by Type (2021-2032) Figure 48. North America GABA Receptor Agonist Drug Revenue Share by Application (2021-2032) Figure 49. North America GABA Receptor Agonist Drug Sales Share by Application (2021-2032) Figure 50. North America GABA Receptor Agonist Drug Revenue Share by Country (2021-2032) Figure 51. North America GABA Receptor Agonist Drug Sales Share by Country (2021-2032) Figure 52. Europe GABA Receptor Agonist Drug Revenue Share by Type (2021-2032) Figure 53. Europe GABA Receptor Agonist Drug Sales Share by Type (2021-2032) Figure 54. Europe GABA Receptor Agonist Drug Revenue Share by Application (2021-2032) Figure 55. Europe GABA Receptor Agonist Drug Sales Share by Application (2021-2032) Figure 56. Europe GABA Receptor Agonist Drug Revenue Share by Country (2021-2032) Figure 57. Europe GABA Receptor Agonist Drug Sales Share by Country (2021-2032) Figure 58. China GABA Receptor Agonist Drug Revenue Share by Type (2021-2032) Figure 59. China GABA Receptor Agonist Drug Sales Share by Type (2021-2032) Figure 60. China GABA Receptor Agonist Drug Revenue Share by Application (2021-2032) Figure 61. China GABA Receptor Agonist Drug Sales Share by Application (2021-2032) Figure 62. Asia GABA Receptor Agonist Drug Revenue Share by Type (2021-2032) Figure 63. Asia GABA Receptor Agonist Drug Sales Share by Type (2021-2032) Figure 64. Asia GABA Receptor Agonist Drug Revenue Share by Application (2021-2032) Figure 65. Asia GABA Receptor Agonist Drug Sales Share by Application (2021-2032) Figure 66. Asia GABA Receptor Agonist Drug Revenue Share by Country (2021-2032) Figure 67. Asia GABA Receptor Agonist Drug Sales Share by Country (2021-2032) Figure 68. SAMEA GABA Receptor Agonist Drug Revenue Share by Type (2021-2032) Figure 69. SAMEA GABA Receptor Agonist Drug Sales Share by Type (2021-2032) Figure 70. SAMEA GABA Receptor Agonist Drug Revenue Share by Application (2021-2032) Figure 71. SAMEA GABA Receptor Agonist Drug Sales Share by Application (2021-2032) Figure 72. SAMEA GABA Receptor Agonist Drug Revenue Share by Country (2021-2032) Figure 73. SAMEA GABA Receptor Agonist Drug Sales Share by Country (2021-2032) Figure 74. GABA Receptor Agonist Drug Value Chain Figure 75. Manufacturing Cost Structure Figure 76. GABA Receptor Agonist Drug Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • Baclofen
  • Bamaluzole
  • Phenibut
  • Gaboxadol
  • Klonopin (clonazepam)
  • Tiagbine
Applications
  • Alzheimer
  • Epilepsy and Seizure
  • Obesity and Alcoholism
  • Anxiety and Sleep Disorders
  • Psychiatric Disorders and Depression
  • Attention Deficit Hyperactivity Disorder (ADHD)
Companies covered
  • Novartis
  • Eli Lilly and Company
  • Pfizer
  • GlaxoSmithKline
  • AstraZeneca
  • XenoPort
  • VIVUS
  • sanofi-aventis
  • OVATION Pharmaceuticals
  • Osmotica Pharmaceutical
  • NovaDel Pharma
  • H.LundBeck, Merck and Co
  • Elan Corporation
  • Biocodex
  • Athena Drug Delivery Solutions
  • Advicenne

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 GABA Receptor Agonist Drug Market by Type
  3. 1.2.1 Global GABA Receptor Agonist Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Baclofen
  5. 1.2.3 Bamaluzole
  6. 1.2.4 Phenibut
  7. 1.2.5 Gaboxadol
  8. 1.2.6 Klonopin (clonazepam)
  9. 1.2.7 Tiagbine
  10. 1.3 GABA Receptor Agonist Drug Market by Application
  11. 1.3.1 Global GABA Receptor Agonist Drug Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Alzheimer
  13. 1.3.3 Epilepsy and Seizure
  14. 1.3.4 Obesity and Alcoholism
  15. 1.3.5 Anxiety and Sleep Disorders
  16. 1.3.6 Psychiatric Disorders and Depression
  17. 1.3.7 Attention Deficit Hyperactivity Disorder (ADHD)
  18. 1.4 Assumptions and Limitations
  19. 1.5 Study Goals and Objectives
2 GABA Receptor Agonist Drug Market Dynamics
  1. 2.1 GABA Receptor Agonist Drug Industry Trends
  2. 2.2 GABA Receptor Agonist Drug Industry Drivers
  3. 2.3 GABA Receptor Agonist Drug Industry Opportunities and Challenges
  4. 2.4 GABA Receptor Agonist Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global GABA Receptor Agonist Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global GABA Receptor Agonist Drug Revenue by Region
  3. 3.2.1 Global GABA Receptor Agonist Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global GABA Receptor Agonist Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global GABA Receptor Agonist Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global GABA Receptor Agonist Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global GABA Receptor Agonist Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global GABA Receptor Agonist Drug Sales by Region
  9. 3.4.1 Global GABA Receptor Agonist Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global GABA Receptor Agonist Drug Sales by Region (2021-2026)
  11. 3.4.3 Global GABA Receptor Agonist Drug Sales by Region (2027-2032)
  12. 3.4.4 Global GABA Receptor Agonist Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global GABA Receptor Agonist Drug Revenue by Manufacturers
  2. 4.1.1 Global GABA Receptor Agonist Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global GABA Receptor Agonist Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global GABA Receptor Agonist Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global GABA Receptor Agonist Drug Sales by Manufacturers
  6. 4.2.1 Global GABA Receptor Agonist Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global GABA Receptor Agonist Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global GABA Receptor Agonist Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global GABA Receptor Agonist Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global GABA Receptor Agonist Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global GABA Receptor Agonist Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global GABA Receptor Agonist Drug Manufacturers, Product Type & Application
  13. 4.7 Global GABA Receptor Agonist Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global GABA Receptor Agonist Drug Market CR5 and HHI
  16. 4.8.2 2025 GABA Receptor Agonist Drug Tier 1, Tier 2, and Tier 3
5 GABA Receptor Agonist Drug Market by Type
  1. 5.1 Global GABA Receptor Agonist Drug Revenue by Type
  2. 5.1.1 Global GABA Receptor Agonist Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global GABA Receptor Agonist Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global GABA Receptor Agonist Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global GABA Receptor Agonist Drug Sales by Type
  6. 5.2.1 Global GABA Receptor Agonist Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global GABA Receptor Agonist Drug Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global GABA Receptor Agonist Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global GABA Receptor Agonist Drug Price by Type
6 GABA Receptor Agonist Drug Market by Application
  1. 6.1 Global GABA Receptor Agonist Drug Revenue by Application
  2. 6.1.1 Global GABA Receptor Agonist Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global GABA Receptor Agonist Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global GABA Receptor Agonist Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global GABA Receptor Agonist Drug Sales by Application
  6. 6.2.1 Global GABA Receptor Agonist Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global GABA Receptor Agonist Drug Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global GABA Receptor Agonist Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global GABA Receptor Agonist Drug Price by Application
7 Company Profiles
  1. 7.1 Novartis
  2. 7.1.1 Novartis Company Information
  3. 7.1.2 Novartis Business Overview
  4. 7.1.3 Novartis GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Novartis GABA Receptor Agonist Drug Product Portfolio
  6. 7.1.5 Novartis Recent Developments
  7. 7.2 Eli Lilly and Company
  8. 7.2.1 Eli Lilly and Company Company Information
  9. 7.2.2 Eli Lilly and Company Business Overview
  10. 7.2.3 Eli Lilly and Company GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Eli Lilly and Company GABA Receptor Agonist Drug Product Portfolio
  12. 7.2.5 Eli Lilly and Company Recent Developments
  13. 7.3 Pfizer
  14. 7.3.1 Pfizer Company Information
  15. 7.3.2 Pfizer Business Overview
  16. 7.3.3 Pfizer GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Pfizer GABA Receptor Agonist Drug Product Portfolio
  18. 7.3.5 Pfizer Recent Developments
  19. 7.4 GlaxoSmithKline
  20. 7.4.1 GlaxoSmithKline Company Information
  21. 7.4.2 GlaxoSmithKline Business Overview
  22. 7.4.3 GlaxoSmithKline GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 GlaxoSmithKline GABA Receptor Agonist Drug Product Portfolio
  24. 7.4.5 GlaxoSmithKline Recent Developments
  25. 7.5 AstraZeneca
  26. 7.5.1 AstraZeneca Company Information
  27. 7.5.2 AstraZeneca Business Overview
  28. 7.5.3 AstraZeneca GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 AstraZeneca GABA Receptor Agonist Drug Product Portfolio
  30. 7.5.5 AstraZeneca Recent Developments
  31. 7.6 XenoPort
  32. 7.6.1 XenoPort Company Information
  33. 7.6.2 XenoPort Business Overview
  34. 7.6.3 XenoPort GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 XenoPort GABA Receptor Agonist Drug Product Portfolio
  36. 7.6.5 XenoPort Recent Developments
  37. 7.7 VIVUS
  38. 7.7.1 VIVUS Company Information
  39. 7.7.2 VIVUS Business Overview
  40. 7.7.3 VIVUS GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 VIVUS GABA Receptor Agonist Drug Product Portfolio
  42. 7.7.5 VIVUS Recent Developments
  43. 7.8 sanofi-aventis
  44. 7.8.1 sanofi-aventis Company Information
  45. 7.8.2 sanofi-aventis Business Overview
  46. 7.8.3 sanofi-aventis GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 sanofi-aventis GABA Receptor Agonist Drug Product Portfolio
  48. 7.8.5 sanofi-aventis Recent Developments
  49. 7.9 OVATION Pharmaceuticals
  50. 7.9.1 OVATION Pharmaceuticals Company Information
  51. 7.9.2 OVATION Pharmaceuticals Business Overview
  52. 7.9.3 OVATION Pharmaceuticals GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 OVATION Pharmaceuticals GABA Receptor Agonist Drug Product Portfolio
  54. 7.9.5 OVATION Pharmaceuticals Recent Developments
  55. 7.10 Osmotica Pharmaceutical
  56. 7.10.1 Osmotica Pharmaceutical Company Information
  57. 7.10.2 Osmotica Pharmaceutical Business Overview
  58. 7.10.3 Osmotica Pharmaceutical GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Osmotica Pharmaceutical GABA Receptor Agonist Drug Product Portfolio
  60. 7.10.5 Osmotica Pharmaceutical Recent Developments
  61. 7.11 NovaDel Pharma
  62. 7.11.1 NovaDel Pharma Company Information
  63. 7.11.2 NovaDel Pharma Business Overview
  64. 7.11.3 NovaDel Pharma GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 NovaDel Pharma GABA Receptor Agonist Drug Product Portfolio
  66. 7.11.5 NovaDel Pharma Recent Developments
  67. 7.12 H.LundBeck, Merck and Co
  68. 7.12.1 H.LundBeck, Merck and Co Company Information
  69. 7.12.2 H.LundBeck, Merck and Co Business Overview
  70. 7.12.3 H.LundBeck, Merck and Co GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 H.LundBeck, Merck and Co GABA Receptor Agonist Drug Product Portfolio
  72. 7.12.5 H.LundBeck, Merck and Co Recent Developments
  73. 7.13 Elan Corporation
  74. 7.13.1 Elan Corporation Company Information
  75. 7.13.2 Elan Corporation Business Overview
  76. 7.13.3 Elan Corporation GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Elan Corporation GABA Receptor Agonist Drug Product Portfolio
  78. 7.13.5 Elan Corporation Recent Developments
  79. 7.14 Biocodex
  80. 7.14.1 Biocodex Company Information
  81. 7.14.2 Biocodex Business Overview
  82. 7.14.3 Biocodex GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Biocodex GABA Receptor Agonist Drug Product Portfolio
  84. 7.14.5 Biocodex Recent Developments
  85. 7.15 Athena Drug Delivery Solutions
  86. 7.15.1 Athena Drug Delivery Solutions Company Information
  87. 7.15.2 Athena Drug Delivery Solutions Business Overview
  88. 7.15.3 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Product Portfolio
  90. 7.15.5 Athena Drug Delivery Solutions Recent Developments
  91. 7.16 Advicenne
  92. 7.16.1 Advicenne Company Information
  93. 7.16.2 Advicenne Business Overview
  94. 7.16.3 Advicenne GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Advicenne GABA Receptor Agonist Drug Product Portfolio
  96. 7.16.5 Advicenne Recent Developments
8 North America
  1. 8.1 North America GABA Receptor Agonist Drug Market Size by Type
  2. 8.1.1 North America GABA Receptor Agonist Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America GABA Receptor Agonist Drug Sales by Type (2021-2032)
  4. 8.1.3 North America GABA Receptor Agonist Drug Price by Type (2021-2032)
  5. 8.2 North America GABA Receptor Agonist Drug Market Size by Application
  6. 8.2.1 North America GABA Receptor Agonist Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America GABA Receptor Agonist Drug Sales by Application (2021-2032)
  8. 8.2.3 North America GABA Receptor Agonist Drug Price by Application (2021-2032)
  9. 8.3 North America GABA Receptor Agonist Drug Market Size by Country
  10. 8.3.1 North America GABA Receptor Agonist Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America GABA Receptor Agonist Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America GABA Receptor Agonist Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe GABA Receptor Agonist Drug Market Size by Type
  2. 9.1.1 Europe GABA Receptor Agonist Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe GABA Receptor Agonist Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe GABA Receptor Agonist Drug Price by Type (2021-2032)
  5. 9.2 Europe GABA Receptor Agonist Drug Market Size by Application
  6. 9.2.1 Europe GABA Receptor Agonist Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe GABA Receptor Agonist Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe GABA Receptor Agonist Drug Price by Application (2021-2032)
  9. 9.3 Europe GABA Receptor Agonist Drug Market Size by Country
  10. 9.3.1 Europe GABA Receptor Agonist Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe GABA Receptor Agonist Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe GABA Receptor Agonist Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China GABA Receptor Agonist Drug Market Size by Type
  2. 10.1.1 China GABA Receptor Agonist Drug Revenue by Type (2021-2032)
  3. 10.1.2 China GABA Receptor Agonist Drug Sales by Type (2021-2032)
  4. 10.1.3 China GABA Receptor Agonist Drug Price by Type (2021-2032)
  5. 10.2 China GABA Receptor Agonist Drug Market Size by Application
  6. 10.2.1 China GABA Receptor Agonist Drug Revenue by Application (2021-2032)
  7. 10.2.2 China GABA Receptor Agonist Drug Sales by Application (2021-2032)
  8. 10.2.3 China GABA Receptor Agonist Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia GABA Receptor Agonist Drug Market Size by Type
  2. 11.1.1 Asia GABA Receptor Agonist Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia GABA Receptor Agonist Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia GABA Receptor Agonist Drug Price by Type (2021-2032)
  5. 11.2 Asia GABA Receptor Agonist Drug Market Size by Application
  6. 11.2.1 Asia GABA Receptor Agonist Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia GABA Receptor Agonist Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia GABA Receptor Agonist Drug Price by Application (2021-2032)
  9. 11.3 Asia GABA Receptor Agonist Drug Market Size by Country
  10. 11.3.1 Asia GABA Receptor Agonist Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia GABA Receptor Agonist Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia GABA Receptor Agonist Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA GABA Receptor Agonist Drug Market Size by Type
  2. 12.1.1 SAMEA GABA Receptor Agonist Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA GABA Receptor Agonist Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA GABA Receptor Agonist Drug Price by Type (2021-2032)
  5. 12.2 SAMEA GABA Receptor Agonist Drug Market Size by Application
  6. 12.2.1 SAMEA GABA Receptor Agonist Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA GABA Receptor Agonist Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA GABA Receptor Agonist Drug Price by Application (2021-2032)
  9. 12.3 SAMEA GABA Receptor Agonist Drug Market Size by Country
  10. 12.3.1 SAMEA GABA Receptor Agonist Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA GABA Receptor Agonist Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA GABA Receptor Agonist Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 GABA Receptor Agonist Drug Value Chain Analysis
  2. 13.1.1 GABA Receptor Agonist Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 GABA Receptor Agonist Drug Production Mode & Process
  6. 13.2 GABA Receptor Agonist Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 GABA Receptor Agonist Drug Distributors
  9. 13.2.3 GABA Receptor Agonist Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst